PT UBC Medical Indonesia TbkISX:LABS +1.45% Market Cap is Rp553,000.00 Mil as of Jul. 04, 2026. The stock has 2 warning signs investors should review. Among 868 Medical Devices & Instruments companies, PT UBC Medical Indonesia Tbk ranks worse than 70.62% on this metric.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT UBC Medical Indonesia Tbk's Enterprise Value for Today is Rp553,000.00 Mil.
PT UBC Medical Indonesia Tbk (ISX:LABS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT UBC Medical Indonesia Tbk Market Cap Related Terms
PT UBC Medical Indonesia Tbk Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT UBC Medical Indonesia Tbk Market Cap Chart
PT UBC Medical Indonesia Tbk Annual Data
Trend
Market Cap
PT UBC Medical Indonesia Tbk Semi-Annual Data
Market Cap
ISX:LABS vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT UBC Medical Indonesia Tbk Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT UBC Medical Indonesia Tbk's Market Cap falls into.
PT UBC Medical Indonesia Tbk Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Market Cap of Rp553,000.00 Mil as of Jul. 04, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT UBC Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT UBC Medical Indonesia Tbk ranks #613 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 70.6%.
Is PT UBC Medical Indonesia Tbk's Market Cap too high?
PT UBC Medical Indonesia Tbk's current Market Cap is Rp553,000.00 Mil. Based on the distribution chart, PT UBC Medical Indonesia Tbk ranks #613 out of 868 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does PT UBC Medical Indonesia Tbk's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT UBC Medical Indonesia Tbk ranks #613 out of 868 companies for Market Cap. This places PT UBC Medical Indonesia Tbk in the lower half of its industry. The industry median Market Cap is 122.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.08, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT UBC Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT UBC Medical Indonesia Tbk's current Market Cap is Rp553,000.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Market Cap of Rp553,000.00 Mil. The current Market Cap is Rp553,000.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Market Cap is Rp553,000.00 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:LABS has been successfully added to your